Navigation Links
Role Of Faith In Healing Process

: "The expectation of pain relief leads to a release of endorphins, the brain's natural pain killers, which is likely to contribute to a sensation of reward and well-being.

"Interestingly, there was an exact split in the range of responses to the placebo; a third of people reporting a reduction in the pain intensity in the "treated" arm only, another third in both arms and the remainder's intensity-ratings not being influenced by the application of the cream. The different responses can be related to the different levels of pain relief the volunteers expected, which may have allowed their individual suggestibility to influence their assessment of the pain experience.

"Our findings suggest that different individuals may have different styles of placebo response, which is likely to affect how they respond to real treatments too. Understanding these differences could better inform the way doctors and nurses provide treatments in the future.

"It could also facilitate more effective clinical trial design, which could substantially reduce the costs of developing new pain killers for patients with conditions like cancer and arthritis.”

"A further, exciting possibility is that we could develop talking and drug-based therapies to enhance people's response to placebos. The experimental methods we're using will allow us to test out such possibilities as a method of treating pain."



Source-Eurekalert
PRI
'"/>




Page: 1 2

Related medicine news :

1. Link between Faith, Health and Healing
2. Prayer and Faith Helps Parents Endure Their Child’s Deat
3. New Approach Needed To Restore Faith in Pharmaceutical Industry
4. Faith May Help Stroke Victims
5. Healing a painful neck
6. Healing environment aids mental problem
7. Blocking Pain Found To Slow Down The Healing Process
8. Energy Therapy For Quicker Healing
9. Link between Faith, Health and Healing
10. Psychological Stress Delays Wound Healing
11. Adult Stem Cells From Fat Tissues For Healing

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Role Faith Healing Process

(Date:11/23/2009).../PRNewswire/--Howistheeconomyaffectingpeople,swell...llnessonWellness&theEconomy,theeconomyismaking...thylifestyleofexerciseanddiettoonethatismoreinward...Thesurvey,smostdramaticfindingwasthechangeinconsum...nalfocusonhealthandwellbeingtotoday,smorerelevantc...
(Date:11/23/2009)... impair breathing, protein may be the cause , ...researchers say they,ve identified a protein that...0 percent of people with chronic sinusitis. , T...inusitis, a constant irritation and swelling of th...f sinus tissue -- can block the sinus passages and...
(Date:11/23/2009)... Exposure shortly after birth to ambient metals fr...s from diesel emissions are associated with respir...ding to a new study by researchers at the Columbia...) at Columbia University,s Mailman School of Publi...ffects of exposure to airborne metals in this very...
(Date:11/23/2009)...a graduate student Jennifer Heys wants to make her...n Ugandan communities about contraception. , He...r desire to bear more children, was read by expert...t the International Conference on Family Planning ...chool of Public Health, spent six months interview...
(Date:11/23/2009)... Plastic and Reconstructive Surgery...In Brief ...dated on the most current journal news from the Am...of the full studies highlighted here, or to arrang... ASPS Public Relations at (847) 228-9900 or media@...cus) November 23, 2009 -- Yes, Plastic Surgeons Ha...
Breaking Medicine News(10 mins):Health News:Being Well Is About Reinvention - Not Health 2Health News:Being Well Is About Reinvention - Not Health 3Health News:Research Yields Clues to Severe Form of Sinusitis 2Health News:Exposures to metals and diesel emissions in air linked to respiratory symptoms in children 2Health News:AIDS research reveals a lack of family-planning programs in Uganda 2Health News:Plastic and Reconstructive Surgery...In Brief 2Health News:Plastic and Reconstructive Surgery...In Brief 3
... Tuesday, May 5, 2009, 5:00 p.m. U.S. EDT , ... Cephalon, Inc . (Nasdaq: CEPH ) has scheduled...vering first quarter 2009 results for 5:00 p.m. ED...articipate in the conference call, dial 913-312-12...
... Medical Center and Anthem Blue Cross and Blue Shi...0 members in northern Nevada and surrounding areas...s, the result of a recently signed contract betwee...tive April 1, 2009, Anthem members will be able to...
...g issued by Randall Terry, founder of Operation Re....C. area Pro-life leaders and activists will gathe...egs regarding conscience for health care workers w...e proposed health reg changes for doctors. , , Pr...
...rove patient safety and enhance outcomes by enabli...tient care , , VENTURA, Calif., March 31 VivoMet...s, integrated and wearable remote patient monitori...(R) hospital patient safety suite, to create a new...
...ns with a Fast and Efficient Way to Query Their Pa...for Clinical Studies and Automation and Eliminatio..., , CARROLLTON, Ga., March 31 Greenway Medical T...lth record (EHR), practice management and interope...
... Systems (NYSE: VAR ) announced today that it wi...r 2009 following the close of regular trading on W...e followed by a teleconference available to all in...n on the conference call webcast will be available...
Other Medicine News:Health News:Saint Mary's Regional Medical Center and Anthem Blue Cross and Blue Shield Join to Enhance Access and Greater Choice in Northern Nevada 2Health News:Saint Mary's Regional Medical Center and Anthem Blue Cross and Blue Shield Join to Enhance Access and Greater Choice in Northern Nevada 3Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 2Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 3Health News:VivoMetrics Partners With OBS Medical to Develop Decision Assist Software for Remote Patient Monitoring 4Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 2Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 3Health News:Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch 4Health News:Varian Medical Systems Schedules Second Quarter FY2009 News Release and Conference Call 2Health News:Varian Medical Systems Schedules Second Quarter FY2009 News Release and Conference Call 3
(Date:11/23/2009)...inker.comannouncesthatanewmarketresearchreportisav...&Equipment-AGlobalMarketPerspective ,, h...Systems--Equipment---A-Global-Market-Perspective.h...m_campaign=prnewswire ,, Steamsterilization...e.Steamsterilizationmarketisstableduetoregulatorye...
(Date:11/23/2009)...3/PRNewswire-USNewswire/--JubilantOrganosys,theUni...rchInstitutetodayannouncedajointventurethatwillfoc...technologiesintheareasofOncology,MetabolicDiseasea...edandleveragedpartnershipthatwillacceleratethedeve...MemorandumofUnderstandingwassignedtodayinWashingto...
(Date:11/23/2009)...endsResearchGroup,Inc.releasedWave2ofits LaunchTr...asesyndicatedmarketresearchprojecttrackingthelaunc...sixmonthsofproductavailability.Eachwaveofthereport...ogistsandqualitativeinformationfromasubsetof15.The...reasonstouse,typicalpatienttypes,productperception...
Breaking Medicine Technology:Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 2Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 3Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 4Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 5Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 6Reportlinker Adds Sterilization Systems & Equipment - A Global Market Perspective 7Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Reported Use of AMAG's Feraheme (ferumoxytol) Continues To Be Low, But a Number of Nephrologists Are 'On the Verge' of Use 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 1US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 2US HIFU Appoints Arie Belldegrun M D to Board of Directors 5229 3US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 1US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 2US Oncology Inc to Exhibit iKnowMed 28TM 29 at the 2009 ASCO EHR Symposium 3A Harnessing the EHR 3A From Incentives to Sustainability 5225 3SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 1SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 2SRI International Awarded National Institute of Mental Health Contract for Evaluation of Brain Imaging Agents and Medications for Treatment of Mental 5221 3
...in is the First Hsp90 Inhibitor to Enter Registrat...iences,Incorporated (Nasdaq: KOSN ) today announc...ement with the U.S. Food and Drug Administration,(... pivotal Phase 3 trial,of its Hsp90 inhibitor tane... myeloma. Through the FDA,s Special Protocol Asses...
...ports Statistically Significant Point Prevalence a...ibody Response; Nabi to Host Conference ... Sept. 5 Nabi,Biopharmaceuticals (Nasdaq: NABI )...trial of NicVAX(R) (Nicotine Conjugate Vaccine), t...ional vaccine being developed to treat,nicotine ad...
Other Medicine Technology:Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 2Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 3Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 4Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 5Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 6Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months 7
Specimen-ID™ for Positive Specimen Identification
IntelliDOT's Bar Code Medication Administration (BCMA) System
wCareMed™
Siemens Med Administration Check
Medicine Products: